Health
The value of a refusal: Research targets engagement gaps in opioid overdose care
The most important people in a clinical trial may be the ones who never join it.
AI Summary
The most important people in a clinical trial may be the ones who never join it. Every "no" in a clinical trial is usually treated as the end of a conversation, but a new MUSC study suggests it might be the beginning of an important one. The study is published in the Journal of Substance Use and Addiction Treatment.
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedEnjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage
- MRI and genetic data find no independent risk from hypertrabeculationContinue reading
- Early mental health support before birth may help prevent postpartum depressionContinue reading
- CDC reportedly expands scope of US cyclosporiasis outbreak to 15 states, including Arkansas and MissouriContinue reading